CAS: 1374248-77-7 - Ubrogepant
Formula:C29H26F3N5O3
InChI:InChI=1S/C29H26F3N5O3/c1-16-20(17-6-3-2-4-7-17)11-22(26(39)37(16)15-29(30,31)32)35-25(38)19-10-18-12-28(13-23(18)34-14-19)21-8-5-9-33-24(21)36-27(28)40/h2-10,14,16,20,22H,11-13,15H2,1H3,(H,35,38)(H,33,36,40)/t16-,20-,22+,28+/m1/s1
InChI key:InChIKey=DDOOFTLHJSMHLN-ZQHRPCGSSA-N
SMILES:O=C(NC1C(=O)N(CC(F)(F)F)C(C)C(C=2C=CC=CC2)C1)C3=CN=C4C(=C3)CC5(C(=O)NC6=NC=CC=C65)C4
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Ubrogepant REF: 4Z-U-018001CAS: 1374248-77-7 | - - - | To inquire | Tue 21 May 24 |
 | Ubrogepant REF: TM-T17194CAS: 1374248-77-7 | 98% | 150.00 €~1,643.00 € | Tue 28 May 24 |
 | Ubrogepant REF: 3D-FU165699CAS: 1374248-77-7 | Min. 95% | 640.00 €~1,752.00 € | Mon 15 Jul 24 |
Ref: 4Z-U-018001
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 21 May 2024
Ubrogepant
CAS:1374248-77-7
Ubrogepant (MK-1602) is an antagonist of calcitonin gene-related peptide receptor that can be used in …
Formula:
C29H26F3N5O3
Purity:
98%
Color and Shape:
Solid
Molecular weight:
549.54
Ref: TM-T17194
| 1mg | 150.00 € | |
| 5mg | 369.00 € | |
| 10mg | 583.00 € | |
| 25mg | 914.00 € | |
| 50mg | 1,198.00 € | |
| 100mg | 1,643.00 € | |
| 1ml*10 (DMSO) | 479.00 € |
Estimated delivery in United States, on Tuesday 28 May 2024
Ubrogepant
CAS:1374248-77-7
Ubrogepant is a small-molecule drug that is used to treat migraine. It inhibits the activity …
Formula:
C29H26F3N5O3
Purity:
Min. 95%
Molecular weight:
549.54 g/mol
Ref: 3D-FU165699
| 1mg | 640.00 € | |
| 2mg | 813.00 € | |
| 5mg | 1,052.00 € | |
| 10mg | 1,752.00 € |
Estimated delivery in United States, on Monday 15 Jul 2024
